TrialEuropean radiology2021

MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).

Simone Giovanni Gugliandolo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.